Spironolactone Contraindications and Precautions
Introduction to Contraindications
- The American College of Cardiology recommends avoiding spironolactone in patients with serum creatinine >2.5 mg/dL in men or >2.0 mg/dL in women, and estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m² 1, 2
Critical Renal Function Thresholds
- The American Heart Association suggests that the risk of life-threatening hyperkalemia increases progressively when serum creatinine exceeds 1.6 mg/dL, making careful patient selection essential 1, 3
High-Risk Populations Requiring Extreme Caution
- Elderly patients, particularly those with low muscle mass, should be monitored intensively due to the risk of hyperkalemia 3, 4, 5
- Diabetic patients have a significantly increased risk of hyperkalemia 3
- Patients with liver disorders require careful consideration due to the potential for increased spironolactone levels 4, 5, 6
Dangerous Drug Combinations
- The European Society of Cardiology recommends avoiding the combination of spironolactone with potassium supplements, other potassium-sparing diuretics, and potent CYP3A4 inhibitors due to the increased risk of hyperkalemia 4, 5, 6
- The American College of Cardiology advises against combining spironolactone with ACE inhibitors and ARB therapy due to the excessive risk of hyperkalemia 7, 8, 2
- NSAIDs and COX-2 inhibitors can precipitate worsening renal function and hyperkalemia, and should be used with caution 3, 8, 2
Clinical Context
- Population-based data demonstrate that hospitalizations for hyperkalemia increased from 2.4 to 11 per thousand patients after widespread adoption of spironolactone, with associated mortality rising from 0.3 to 2 per thousand 3, 8, 2
- Hyperkalemia occurred in 24% of patients receiving spironolactone in routine practice, with half having potassium levels exceeding 6 mEq/L 3, 8